about
Cervical preparation for first trimester surgical abortionSurgical versus medical methods for second trimester induced abortionOral contraceptives and breakthrough bleeding: what patients need to know.Use of the Mirena LNG-IUS and Paragard CuT380A intrauterine devices in nulliparous women.Chlamydia screening and prophylactic treatment in termination of pregnancy clinics in the Netherlands and Great Britain: a qualitative study.Outcomes with same-day cervical preparation with Dilapan-S osmotic dilators and vaginal misoprostol before dilatation and evacuation at 18 to 21+6 weeks' gestation.Experiences of women who travel to England for abortions: an exploratory pilot study.Use of intrauterine devices in nulliparous women.RU OK? The acceptability and feasibility of remote technologies for follow-up after early medical abortion.Provision of contraceptive counseling by internal medicine residents.Disposal of fetal tissue following elective abortion: what women think.Treatment of fibroids: the use of beets (Beta vulgaris) and molasses (Saccharum officinarum) as an herbal therapy by Dominican healers in New York City.Endometrial thickness following medical abortion is not predictive of subsequent surgical intervention.Ultrasonographic endometrial thickness after medical and surgical management of early pregnancy failure.Mandatory submission of patient identifiable information to third parties: FGM now, what next?Contraceptive method preferences and provision after termination of pregnancy: a population-based analysis of women obtaining care with the British Pregnancy Advisory Service.Abortion terminology: views of women seeking abortion in Britain.Oral Contraceptives in Women with Systemic Lupus ErythematosusTelephone or integrated contraception counselling before abortion: impact on method choice and receiptSimultaneous Compared With Interval Medical Abortion Regimens Where Home Use Is RestrictedTermination for fetal anomaly: Are women in England given a choice of method?Doxycycline serum levels at the time of dilation and evacuation with two dosing regimensSurgical Abortion in the Second TrimesterOral mifepristone and buccal misoprostol administered simultaneously for abortion: a pilot studySurgical or medical abortion of pregnancies between 13+0 and 23+6 weeks' gestation? A systematic review and new NICE national guidelinesSurgical termination of pregnancy for fetal anomaly: what role can an independent abortion service provider play?
P50
Q24240070-58D9C9C1-ADC4-4C0F-9D93-464084B27019Q24242713-5290F2EE-DE37-4A6E-A432-356B0A49EE17Q36609985-EF63A4B0-D463-4BDC-93E7-1FF7C9FCC94FQ37732949-68AC3819-805B-4392-BDB2-C68E421F2C89Q37835635-BA136DED-23A1-4869-B4E7-CA0DDDD1731CQ38035112-61DA758E-45B0-421B-AC3B-BC753C29A8D7Q38830038-DF3DA53F-31D3-40C3-8E51-0A2C879D7D09Q38945630-D53ADDFD-6176-4DC4-A845-96E07EA74AB5Q39195062-29375767-496E-40A8-9BB4-6133B3DCF4FBQ40019444-9CB74964-52E2-49F1-BD90-0D9A1DC1ABADQ43322888-BA32B68B-746D-4463-BD2B-9BF5D1FED496Q43496473-E227AD72-FE2F-4F24-8ABA-8460F035DF86Q45973770-A9D75430-0015-4AF3-B28F-712D46D0D7A8Q46828415-47647102-C31C-4981-A671-47B7A36CAC6EQ47375301-13CCAE4E-3C5C-4BD0-9A31-63A284C834EFQ48658605-E52A0DD2-69E0-4AA8-8292-CD5321BC9CD8Q54279351-C24BF5A7-E2E9-4DCE-B6FA-1F010F90843BQ57716433-2A0B556B-CDB3-4A34-94E9-DC3284ED0691Q58224280-12E58979-B47C-4E69-9A87-66CBF9E43641Q58224282-9A0D3D6F-83DA-473E-B5F4-AA1D31029813Q58224291-F3E3AA29-E015-4B57-BF65-5FE3C0ADE84CQ58224300-52D43A3F-4019-4C1A-A702-5F46BE1440B9Q58224302-E3B15AC9-C633-4736-9404-8A52C448EDE3Q58224305-0AE3B164-3522-4AFA-8734-72A279403762Q90407327-03D27585-80DB-42B4-A930-CBD6F306C926Q93183483-5AE2F169-41DA-413A-8C53-BF2E12A802AC
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Patricia A Lohr
@ast
Patricia A Lohr
@en
Patricia A Lohr
@es
Patricia A Lohr
@nl
type
label
Patricia A Lohr
@ast
Patricia A Lohr
@en
Patricia A Lohr
@es
Patricia A Lohr
@nl
prefLabel
Patricia A Lohr
@ast
Patricia A Lohr
@en
Patricia A Lohr
@es
Patricia A Lohr
@nl
P106
P21
P31
P496
0000-0003-1862-5730